NASDAQ:CRON - Cronos Group Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cronos Group Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $6.29 -0.03 (-0.47 %) (As of 03/29/2020 02:27 PM ET) Add Compare Today's Range$6.11Now: $6.29▼$6.6350-Day Range$4.52MA: $6.18▼$7.3452-Week Range$4.00Now: $6.29▼$19.28Volume6.32 million shsAverage Volume6.87 million shsMarket Capitalization$2.19 billionP/E Ratio7.23Dividend YieldN/ABeta3.03 ProfileAnalyst RatingsAdvanced ChartEarningsInstitutional OwnershipHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations MMPR. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in Toronto, Canada.Read More Industry, Sector and Symbol Stock Exchange NASDAQ Industry Medicinals & botanicals Sub-IndustryN/A SectorFinance Current SymbolNASDAQ:CRON Previous Symbol CUSIPN/A CIKN/A Webhttp://www.thecronosgroup.com/ Phone212-590-9070Debt Debt-to-Equity RatioN/A Current Ratio3.45 Quick Ratio3.36Price-To-Earnings Trailing P/E Ratio7.23 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$12.12 million Price / Sales181.03 Cash FlowN/A Price / Cash FlowN/A Book Value$0.91 per share Price / Book6.91Profitability EPS (Most Recent Fiscal Year)($0.08) Net Income$-14,640,000.00 Net Margins4,086.41% Return on Equity31.88% Return on Assets17.34%Miscellaneous Employees291 Outstanding Shares348,820,000Market Cap$2.19 billion Next Earnings DateN/A OptionableOptionable Receive CRON News and Ratings via Email Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:CRON Rates by TradingView Cronos Group (NASDAQ:CRON) Frequently Asked Questions How has Cronos Group's stock been impacted by COVID-19 (Coronavirus)? Cronos Group's stock was trading at $5.41 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CRON shares have increased by 16.3% and is now trading at $6.29. View which stocks have been mosted impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Cronos Group? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Cronos Group. What price target have analysts set for CRON? 9 brokerages have issued twelve-month target prices for Cronos Group's stock. Their forecasts range from $8.00 to $26.00. On average, they expect Cronos Group's stock price to reach $14.71 in the next year. This suggests a possible upside of 133.9% from the stock's current price. View analysts' price targets for Cronos Group. Has Cronos Group been receiving favorable news coverage? Media stories about CRON stock have trended extremely negative on Sunday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cronos Group earned a media sentiment score of -4.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutCronos Group. Are investors shorting Cronos Group? Cronos Group saw a decrease in short interest in the month of March. As of March 13th, there was short interest totaling 57,198,900 shares, a decrease of 10.6% from the February 27th total of 63,950,000 shares. Based on an average daily trading volume, of 6,043,900 shares, the short-interest ratio is currently 9.5 days. Approximately 32.1% of the shares of the company are sold short. View Cronos Group's Current Options Chain. Who are some of Cronos Group's key competitors? Some companies that are related to Cronos Group include Canopy Growth (CGC), STADA Arzneimittel (STDAF), USANA Health Sciences (USNA), Aurora Cannabis (ACB), Tilray (TLRY), Canopy Rivers (RIV), Foamix Pharmaceuticals (FOMX), Chromadex (CDXC), Sundial Growers (SNDL), Happiness Biotech Group (HAPP), Mediwound (MDWD), Natural Alternatives International (NAII), Mannatech (MTEX), True Drinks (TRUU) and Cyanotech (CYAN). What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Tilray (TLRY), Dollar Tree (DLTR), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Micron Technology (MU), Alibaba Group (BABA) and KushCo (KSHB). Who are Cronos Group's key executives? Cronos Group's management team includes the following people: Mr. Michael Gorenstein, Chairman, Pres & CEO (Age 31)Mr. David Hsu, Chief Operating OfficerMs. Xiuming Shum, Gen. Counsel & Corp. Sec.Mr. Jeffrey Jacobson, Head of Sales & Bus. Devel.Mr. William Hilson, Chief Commercial Officer What is Cronos Group's stock symbol? Cronos Group trades on the NASDAQ under the ticker symbol "CRON." Who are Cronos Group's major shareholders? Cronos Group's stock is owned by a variety of retail and institutional investors. Top institutional investors include Chescapmanager LLC (2.54%), Sumitomo Mitsui Trust Holdings Inc. (0.19%), Swiss National Bank (0.19%), Bank of America Corp DE (0.17%), UBS Asset Management Americas Inc. (0.16%) and Berylson Capital Partners LLC (0.16%). Which major investors are selling Cronos Group stock? CRON stock was sold by a variety of institutional investors in the last quarter, including Alberta Investment Management Corp, Swiss National Bank, Exane Derivatives, UBS Asset Management Americas Inc., Janus Henderson Group PLC, Public Sector Pension Investment Board, TD Asset Management Inc., and Creative Planning. Which major investors are buying Cronos Group stock? CRON stock was purchased by a variety of institutional investors in the last quarter, including Connor Clark & Lunn Investment Management Ltd., Connor Clark & Lunn Investment Management Ltd., Chescapmanager LLC, Berylson Capital Partners LLC, Virtu Financial LLC, Wedbush Securities Inc., Oxford Asset Management LLP, and BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp. How do I buy shares of Cronos Group? Shares of CRON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Cronos Group's stock price today? One share of CRON stock can currently be purchased for approximately $6.29. How big of a company is Cronos Group? Cronos Group has a market capitalization of $2.19 billion and generates $12.12 million in revenue each year. The company earns $-14,640,000.00 in net income (profit) each year or ($0.08) on an earnings per share basis. Cronos Group employs 291 workers across the globe. View additional information about Cronos Group. What is Cronos Group's official website? The official website for Cronos Group is http://www.thecronosgroup.com/. How can I contact Cronos Group? Cronos Group's mailing address is 720 KING STREET W SUITE 320, TORONTO A6, M5V 2T3. The company can be reached via phone at 212-590-9070. MarketBeat Community Rating for Cronos Group (NASDAQ CRON)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 424 (Vote Outperform)Underperform Votes: 488 (Vote Underperform)Total Votes: 912MarketBeat's community ratings are surveys of what our community members think about Cronos Group and other stocks. Vote "Outperform" if you believe CRON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRON will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/29/2020 by MarketBeat.com StaffFeatured Article: What is the Nikkei 225 index?
